title: Is there a link between hyperuricemia, morning blood pressure surge, and non-dipping blood pressure pattern in metabolic syndrome patients?
abstract: BACKGROUND
  Hypertensive patients usually have a blunted nocturnal decrease, or even increase, in blood pressure during sleep. There is also a tendency for increased occurrence of cardiovascular events between 6 and 12 am due to increased morning blood pressure surge (MBPS). Co-occurrence of metabolic syndrome (MetS) and hypertension is also a common problem. Hyperuricemia might trigger the development of hypertension, chronic renal failure, and insulin resistance. In this study, we aimed to determine whether there is a relationship between hyperuricemia, MetS, nocturnal blood pressure changes, and MBPS.
  
  
  METHODS
  A total of 81 newly diagnosed hypertensive MetS patients were included in this study. Ambulatory blood pressure monitoring of patients was done and patients' height, weight, and waist and hip circumferences were recorded. Fasting blood glucose (FBG), lipid profile, creatinine, potassium, uric acid, hematocrit levels were studied.
  
  
  RESULTS
  Non-dipper (ie, those whose blood pressure did not drop overnight) patients had higher waist-hip ratios (WHR) (P = 0.003), uric acid (P = 0.0001), FBG (P = 0.001), total and low-density lipoprotein cholesterol levels (P = 0.0001). Risk analysis revealed that hyperuricemia was a risk factor for non-dipping pattern (P < 0.0001, odds ratio = 8.1, 95% confidence interval = 1.9-33.7). Patients in the highest quadrant for uric acid levels had higher FBG (P = 0.001), low-density lipoprotein cholesterol (P = 0.017), WHR (P = 0.01), MBPS (P = 0.003), and night diastolic blood pressure compared with lowest quadrant patients (P = 0.013). Uric acid levels were also positively correlated with night ambulatory blood pressure (ABP) (r = 0.268, P =0.05), night diastolic blood pressure (r =0.3, P =0.05), and MBPS (r =0.3, P =0.05).
  
  
  CONCLUSIONS
  Evaluation of hypertensive patients should also include an assessment of uric acid level and anthropometric measurements such as abdominal obesity. Hyperuricemia seems to be closely related to undesired blood pressure patterns and this may signal to the clinician that an appropriate therapeutic approach is required.
authors: Department of Nephrology, Baskent University Hospital, Ankara, Turkey.
authors: Emre
authors: E
authors: Tutal
authors: Burak
authors: B
authors: Sayın
authors: Derun Taner
authors: DT
authors: Ertugrul
authors: Avsin
authors: A
authors: Ibis
authors: Siren
authors: S
authors: Sezer
authors: Nurhan
authors: N
authors: Ozdemir
keywords: hypertension; non-dipper; uric acid
references: Circulation. 2004 Jun 1;109(21):2507-10
references: 15136499
references: J Clin Invest. 1996 Jun 1;97(11):2601-10
references: 8647954
references: Arthritis Rheum. 2009 Jul 15;61(7):885-92
references: 19565556
references: Am J Hypertens. 2004 Aug;17(8):668-75
references: 15288883
references: Am J Physiol. 1995 Jan;268(1 Pt 1):E1-5
references: 7840165
references: Am J Hypertens. 2006 Oct;19(10):1055-62
references: 17027827
references: J Rheumatol. 2009 Aug;36(8):1691-8
references: 19531754
references: Hypertension. 1989 Oct;14(4):367-74
references: 2676858
references: Metabolism. 2007 Jun;56(6):751-6
references: 17512306
references: Diabetes Care. 2009 Sep;32(9):1716-20
references: 19542211
references: JAMA. 2001 May 16;285(19):2486-97
references: 11368702
references: J Intern Med. 2009 Dec;266(6):558-70
references: 19563390
references: Hypertension. 2005 Jan;45(1):28-33
references: 15569852
references: Stroke. 1989 Apr;20(4):473-6
references: 2648651
references: Fiziol Zh. 2009;55(3):133-40
references: 19526867
references: Int J Obes Relat Metab Disord. 2004 Mar;28(3):402-9
references: 14724659
references: Hypertension. 1994 Mar;23(3):381-94
references: 8125566
references: Diabetes Care. 1996 May;19(5):414-8
references: 8732701
references: Hypertens Res. 2002 Jul;25(4):543-51
references: 12358139
references: Nihon Rinsho. 1996 Dec;54(12):3293-6
references: 8976108
references: Curr Pharm Des. 2013;19(27):4930-7
references: 23278493
references: Circulation. 1989 Apr;79(4):733-43
references: 2647318
references: Circ J. 2005 Aug;69(8):928-33
references: 16041161
references: Hypertension. 2003 Dec;42(6):1206-52
references: 14656957
references: Lancet. 2002 Dec 14;360(9349):1903-13
references: 12493255
references: Hypertens Res. 2002 Jul;25(4):499-506
references: 12358133
references: Am J Cardiol. 2003 Dec 15;92(12):1439-41
references: 14675581
references: Isr Med Assoc J. 2012 Nov;14(11):676-80
references: 23240372
references: Circulation. 2003 Mar 18;107(10):1401-6
references: 12642361
references: N Engl J Med. 1996 Feb 8;334(6):374-81
references: 8538710
references: Curr Hypertens Rep. 2010 Apr;12(2):113-9
references: 20424936
references: Horm Metab Res. 1990 Dec;22(12):636-9
references: 2076861
references: Am J Kidney Dis. 2013 Jan;61(1):134-46
references: 23058478